Literature DB >> 24983456

Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain.

Debbie Le Blon1, Chloé Hoornaert1, Jasmijn Daans1, Eva Santermans2, Niel Hens3, Herman Goossens4, Zwi Berneman1, Peter Ponsaerts1.   

Abstract

Although implantation of cellular material in the central nervous system (CNS) is a key direction in CNS regenerative medicine, this approach is currently limited by the occurrence of strong endogenous immune cell responses. In a model of mesenchymal stem cell (MSC) grafting in the CNS of immune-competent mice, we previously described that MSC grafts become highly surrounded and invaded by Iba1(+) myeloid cells (microglia and/or macrophages). Here, following grafting of blue fluorescent protein (BFP)-expressing MSC in the CNS of CX3CR1(+/-) and CX3CR1(-/-) mice, our results indicate: (1) that the observed inflammatory response is independent of the fractalkine signalling axis, and (2) that a significant spatial distribution of Iba1(+) inflammatory cells occurs, in which Iba1(+) CX3CR1(+) myeloid cells mainly surround the MSC graft and Iba1(+) CX3CR1(-) myeloid cells mainly invade the graft at 10 days post transplantation. Although Iba1(+) CX3CR1(+) myeloid cells are considered to be of resident microglial origin, Iba1(+) CX3CR1(-) myeloid cells are most likely of peripheral monocyte/macrophage origin. In order to confirm the latter, we performed MSC-BFP grafting experiments in the CNS of eGFP(+) bone marrow chimeric C57BL/6 mice. Analysis of MSC-BFP grafts in the CNS of these mice confirmed our observation that peripheral monocytes/macrophages invade the MSC graft and that resident microglia surround the MSC graft site. Furthermore, analysis of major histocompatibility complex class II (MHCII) expression revealed that mainly macrophages, but not microglia, express this M1 pro-inflammatory marker in the context of MSC grafting in the CNS. These results again highlight the complexity of cell implantation immunology in the CNS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24983456     DOI: 10.1038/icb.2014.49

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  18 in total

1.  Ethyl pyruvate does not require microglia for mediating neuroprotection after excitotoxic injury.

Authors:  Philipp Pieroh; Daniel-Christoph Wagner; Chalid Ghadban; Gerd Birkenmeier; Faramarz Dehghani
Journal:  CNS Neurosci Ther       Date:  2017-08-23       Impact factor: 5.243

2.  Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis.

Authors:  Lixia Luo; Jin Yang; Yumin Oh; Matthew J Hartsock; Shiyu Xia; Yoo-Chun Kim; Zheng Ding; Tuo Meng; Charles G Eberhart; Laura M Ensign; Jennifer E Thorne; Walter J Stark; Elia J Duh; Qingguo Xu; Justin Hanes
Journal:  J Control Release       Date:  2019-01-17       Impact factor: 9.776

3.  The gut microbiome regulates the increases in depressive-type behaviors and in inflammatory processes in the ventral hippocampus of stress vulnerable rats.

Authors:  Jiah Pearson-Leary; Chunyu Zhao; Kyle Bittinger; Darrell Eacret; Sandra Luz; Abigail S Vigderman; Gabriel Dayanim; Seema Bhatnagar
Journal:  Mol Psychiatry       Date:  2019-03-04       Impact factor: 15.992

4.  Interleukin-25 is detrimental for recovery after spinal cord injury in mice.

Authors:  Dearbhaile Dooley; Evi Lemmens; Peter Ponsaerts; Sven Hendrix
Journal:  J Neuroinflammation       Date:  2016-05-06       Impact factor: 8.322

5.  Intracerebral transplantation of interleukin 13-producing mesenchymal stem cells limits microgliosis, oligodendrocyte loss and demyelination in the cuprizone mouse model.

Authors:  Debbie Le Blon; Caroline Guglielmetti; Chloé Hoornaert; Alessandra Quarta; Jasmijn Daans; Dearbhaile Dooley; Evi Lemmens; Jelle Praet; Nathalie De Vocht; Kristien Reekmans; Eva Santermans; Niel Hens; Herman Goossens; Marleen Verhoye; Annemie Van der Linden; Zwi Berneman; Sven Hendrix; Peter Ponsaerts
Journal:  J Neuroinflammation       Date:  2016-11-09       Impact factor: 8.322

6.  Differences in the Cellular Response to Acute Spinal Cord Injury between Developing and Mature Rats Highlights the Potential Significance of the Inflammatory Response.

Authors:  Theresa C Sutherland; Kathryn J Mathews; Yilin Mao; Tara Nguyen; Catherine A Gorrie
Journal:  Front Cell Neurosci       Date:  2017-01-13       Impact factor: 5.505

7.  Cell-Based Delivery of Interleukin-13 Directs Alternative Activation of Macrophages Resulting in Improved Functional Outcome after Spinal Cord Injury.

Authors:  Dearbhaile Dooley; Evi Lemmens; Tim Vangansewinkel; Debbie Le Blon; Chloé Hoornaert; Peter Ponsaerts; Sven Hendrix
Journal:  Stem Cell Reports       Date:  2016-12-13       Impact factor: 7.765

8.  Inflammation and vascular remodeling in the ventral hippocampus contributes to vulnerability to stress.

Authors:  J Pearson-Leary; D Eacret; R Chen; H Takano; B Nicholas; S Bhatnagar
Journal:  Transl Psychiatry       Date:  2017-06-27       Impact factor: 6.222

9.  Infiltrating cells from host brain restore the microglial population in grafted cortical tissue.

Authors:  Cong Wang; Sijue Tao; Yukun Fang; Jing Guo; Lirui Zhu; Shengxiang Zhang
Journal:  Sci Rep       Date:  2016-09-12       Impact factor: 4.379

10.  Immunosuppressant Drugs Mitigate Immune Responses Generated by Human Mesenchymal Stem Cells Transplanted into the Mouse Parenchyma.

Authors:  Jung Won Hwang; Su Hyeon Myeong; Na-Hee Lee; Hyeongseop Kim; Hyo Jin Son; Jong Wook Chang; Na Kyung Lee; Duk L Na
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.